Half life of Rn-222 is:
**Core Concept:**
Rn-222, also known as Radon-222, is a radioactive gas that belongs to the uranium series formed by the radioactive decay of Thorium-226. The half-life of a radioactive substance is the time it takes for half of the initial quantity to decay. In the context of medical science, understanding radioactive decay can help explain the behavior of radioactive isotopes used in nuclear medicine.
**Why the Correct Answer is Right:**
The half-life of Rn-222 is 3.8 days. This means that after 3.8 days, half of the initial quantity of Rn-222 will have decayed. In the context of nuclear medicine, this understanding helps radiologists and nuclear physicians interpret and analyze the data obtained from radioactive tracer studies, such as bone scans and lung scans.
**Why Each Wrong Option is Incorrect:**
A. This option is incorrect because the half-life of Rn-222 is not 7 days.
B. This option is incorrect because the half-life of Rn-222 is not 14 days.
C. This option is incorrect because the half-life of Rn-222 is not 28 days.
D. This option is incorrect because the half-life of Rn-222 is not 35 days.
**Why the Correct Answer is Right:**
The half-life of Rn-222 is 3.8 days. This value is derived from the radioactive decay properties of Rn-222, which follows the exponential decay model. The exponential decay model is used to describe the decay of radioactive isotopes over time. When the decay occurs, the radioactive isotope is converted into another isotope, in this case, Polonium-218.
**Why Each Wrong Option is Incorrect:**
A. This option is incorrect because the half-life of Rn-222 is shorter than 7 days.
B. This option is incorrect because the half-life of Rn-222 is not 14 days.
C. This option is incorrect because the half-life of Rn-222 is shorter than 28 days.
D. This option is incorrect because the half-life of Rn-222 is shorter than 35 days.
**Clinical Application:**
Understanding the half-life of Rn-222 allows radiologists and nuclear medicine physicians to accurately interpret and analyze the data obtained from radioactive tracer studies, like bone scans and lung scans, as it helps them determine the optimal timing for obtaining images to capture the decay of the radiotracer within the body. This information is crucial for diagnosing various diseases and monitoring treatment progress in nuclear medicine.